These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35966291)

  • 1. Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER database.
    Yang R; Gong J; Liao Z; Yu J; Zhang J; Xie C
    Transl Cancer Res; 2022 Jul; 11(7):2194-2204. PubMed ID: 35966291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients.
    Gao F; Li N; Xu Y; Yang G
    Front Oncol; 2020; 10():1135. PubMed ID: 32850322
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of postoperative radiotherapy on the survival of patients with stage III non-small cell lung cancer: A CONSORT-compliant analysis using the SEER database.
    Wu K; Peng W; Shuai Z; Peng X; Liu H; Zhang S
    Medicine (Baltimore); 2023 Jun; 102(24):e34015. PubMed ID: 37327271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high-risk features and effect of postoperative radiotherapy on survival for patients with surgically treated stage IIIA-N2 non-small cell lung cancer.
    Zhu M; Li S; Yuan L; Liu S; Li J; Zhang D; Chen J; Jiang J; Xu Z
    World J Surg Oncol; 2023 Aug; 21(1):238. PubMed ID: 37537652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
    Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
    Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non-small cell lung cancer: A population-based study.
    Xu L; Xie HN; Chen XK; Bi N; Qin JJ; Li Y
    Thorac Cancer; 2021 Mar; 12(6):760-767. PubMed ID: 33481353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
    Gao F; Li N; Xu Y; Yang G
    J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.
    Jin X; Chen D; Shen Y; Shu J; Sang Y; Yang W; Duan S; Chen Y
    Thorac Cancer; 2022 Oct; 13(19):2767-2775. PubMed ID: 36054738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
    Wei S; Xie M; Tian J; Song X; Wu B; Liu L
    Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER database.
    Wang X; Song J; Long J; Zeng Z; Liu A
    Radiat Oncol; 2021 Sep; 16(1):184. PubMed ID: 34544464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Sun X; Men Y; Wang J; Bao Y; Yang X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
    Thorac Cancer; 2021 May; 12(9):1358-1365. PubMed ID: 33728811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
    Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
    Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.
    Duan H; Liang L; Xie S; Wang C
    BMC Cancer; 2020 Aug; 20(1):809. PubMed ID: 32847544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male patients with resected IIIA-N2 non-small-cell lung cancer may benefit from postoperative radiotherapy: a population-based survival analysis.
    Kou P; Wang H; Lin J; Zhang Y; Yu J
    Future Oncol; 2018 Oct; 14(23):2371-2381. PubMed ID: 29807451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of postoperative radiotherapy in right tumor for lung related death: based on SEER database and real-world data.
    Mo Y; Chen M; Wang M; Wu M; Yu J
    Front Oncol; 2023; 13():1178064. PubMed ID: 37091143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
    Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
    J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach.
    Deng W; Xu T; Xu Y; Wang Y; Liu X; Zhao Y; Yang P; Liao Z
    J Thorac Oncol; 2018 Dec; 13(12):1968-1974. PubMed ID: 30194035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.